Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.290
+0.120 (10.26%)
At close: Jun 26, 2026, 4:00 PM EDT
1.260
-0.030 (-2.33%)
After-hours: Jun 26, 2026, 7:56 PM EDT
Dermata Therapeutics Employees
Dermata Therapeutics had 9 employees as of December 31, 2025. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$789,186
Market Cap
5.19M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| GeoVax Labs | 19 |
| Genprex | 13 |
| TransCode Therapeutics | 12 |
| Processa Pharmaceuticals | 12 |
| Enveric Biosciences | 6 |
| Alzamend Neuro | 6 |
| Mustang Bio | 4 |
DRMA News
- 5 weeks ago - Dermata Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 - Accesswire
- 6 weeks ago - Dermata Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Dermata Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Dermata Therapeutics Proxy statement: Proxy filing - Filings
- 3 months ago - Dermata receives notice of acceptance of Australian patent application - TheFly